NBTS Names Dr. Manmeet Ahluwalia Clinical Advisor to its DNA Damage Response Consortium Today, the National Brain Tumor Society (NBTS) announced that Manmeet Ahluwalia, MD, MBA, FASCO, Chief Scientific Officer, Chief of Medical Oncology, Deputy Director, and Fernandez Family Endowed Chair at Miami Cancer Institute, part of Baptist Health South Florida, is joining its DNA Damage Response Consortium as Clinical Advisor. The consortium –– which comprises expert teams […] October 25, 2023
Leading Institute Joins Consortium on DNA Damage Response Treatments for Adults and Children with Brain Cancer Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced that Jann Sarkaria, MD, radiation oncologist, and co-leader of the Mayo Clinic Comprehensive Cancer Center Neuro-oncology program, is joining its DNA Damage Response Consortium. The consortium — which also comprises experts from St. Jude Children’s Research Hospital; Dana-Farber Cancer Institute; New […] August 31, 2023
Top Boston Hospitals Latest to Join Consortium Bringing Forward DNA Damage Response Treatments for Adults and Children with Brain Cancer Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced that experts from Dana-Farber Cancer Institute and Brigham & Women’s Hospital are joining its DNA Damage Response Consortium. The consortium — which also comprises teams from St. Jude Children’s Research Hospital; New York University Grossman School of Medicine (NYU); the University […] June 27, 2023
World Class Hospitals Join DNA Damage Response Consortium to Bring Forward New Treatments for Adults and Children with Brain Cancer Researchers from St. Jude Children’s Research Hospital, NYU, UCSF, and the University of Minnesota join National Brain Tumor Society and Yale-led Initiative Today, the National Brain Tumor Society (NBTS), in partnership with Yale Cancer Center, announced new partners for its DNA Damage Response Consortium. Joining the initiative are world-class experts in adult and pediatric neuro-oncology […] March 28, 2023